L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma ModelPaola Orecchia, Barbara Carnemolla, Gabriella Pietra et al.|Cancers|2019Cited by 24